Notes
Of note, the reviewed literature and critique by Pyke and Clayton (Citation2015) focus on the diagnosis of HSDD as defined in the DSM-IV-TR (American Psychiatric Association, Citation2000). As far as we are aware, there have been no published studies on psychological or pharmacological treatment of the new DSM-5 (American Psychiatric Association, Citation2013) condition, female sexual interest/arousal disorder (FSIAD).
CONSORT is an acronym for Consolidated Standards of Reporting Trials.